Meronem Humulin R Gouric Ascard Bone-Lift 0.5mcg Vadil Metxone Lanoxin Lasix Rovista 10mg Saltra 250mcg Alp Cap Tephinsta 40 Tell me the generic name,their MOA,indications,and side effects of all these medications shortly
Reading File
Given the large number of drugs and budget constraints, I'll answer from established pharmacological knowledge for all 13 medications. Let me identify them and provide the requested information.
Meronem = Meropenem | Humulin R = Regular Insulin | Gouric = Febuxostat | Ascard = Aspirin (low-dose) | Bone-Lift 0.5mcg = Calcitriol | Vadil = Amlodipine | Metxone = Methadone | Lanoxin = Digoxin | Lasix = Furosemide | Rovista 10mg = Rosuvastatin | Saltra 250mcg = Salmeterol | Alp = Alprazolam | Cap Tephinsta 40 = Pantoprazole (Tephinsta brand)
1. Meronem — Meropenem
MOA: Beta-lactam carbapenem; inhibits bacterial cell wall synthesis by binding penicillin-binding proteins (PBPs), causing cell lysis.
Indications: Severe/complicated infections — intra-abdominal infections, meningitis, hospital-acquired pneumonia, sepsis, febrile neutropenia, UTIs caused by multidrug-resistant organisms.
Side Effects: Diarrhea, nausea/vomiting, headache, injection site reactions, thrombocytopenia, elevated liver enzymes, seizures (high doses/renal impairment), hypersensitivity reactions.
2. Humulin R — Regular Insulin (Short-acting)
MOA: Binds insulin receptors → activates GLUT4 transporter → increases glucose uptake into cells; suppresses gluconeogenesis and glycogenolysis; promotes glycogen, fat, and protein synthesis.
Indications: Type 1 & Type 2 diabetes mellitus, diabetic ketoacidosis (DKA), hyperkalemia (with dextrose), perioperative glucose control, hyperglycemic hyperosmolar state.
Side Effects: Hypoglycemia (most common), lipodystrophy at injection site, weight gain, hypokalemia, local allergic reactions.
3. Gouric — Febuxostat
MOA: Selective non-purine xanthine oxidase inhibitor → reduces conversion of hypoxanthine and xanthine to uric acid → lowers serum uric acid levels.
Indications: Chronic hyperuricemia in gout, prevention of gout flares, tumor lysis syndrome (off-label).
Side Effects: Gout flares (initial therapy), liver enzyme elevation, nausea, arthralgia, rash, increased cardiovascular events (use caution in CV disease).
4. Ascard — Aspirin (75–100 mg, low-dose)
MOA: Irreversibly inhibits COX-1 and COX-2 enzymes → prevents thromboxane A₂ synthesis → reduces platelet aggregation (antiplatelet effect at low dose).
Indications: Primary/secondary prevention of MI and stroke, acute coronary syndrome, post-PCI/CABG, ischemic stroke/TIA, peripheral arterial disease.
Side Effects: GI irritation/bleeding, peptic ulcer, bruising, tinnitus (high dose), hypersensitivity (aspirin-exacerbated respiratory disease), Reye's syndrome (in children).
5. Bone-Lift 0.5 mcg — Calcitriol (1,25-dihydroxyvitamin D₃)
MOA: Active form of vitamin D; binds vitamin D receptors in intestine → increases calcium and phosphate absorption; promotes bone mineralization; suppresses PTH secretion.
Indications: Hypoparathyroidism, renal osteodystrophy (CKD), osteoporosis, hypocalcemia, secondary hyperparathyroidism.
Side Effects: Hypercalcemia, hypercalciuria, nephrolithiasis, nephrocalcinosis, nausea, weakness, metastatic calcification (overdose).
6. Vadil — Amlodipine
MOA: Dihydropyridine calcium channel blocker (CCB); blocks L-type voltage-gated calcium channels in vascular smooth muscle and cardiomyocytes → vasodilation → reduces peripheral vascular resistance and blood pressure.
Indications: Hypertension, stable angina pectoris, vasospastic (Prinzmetal's) angina, coronary artery disease.
Side Effects: Peripheral edema (most common), flushing, headache, dizziness, palpitations, gingival hyperplasia (rare).
7. Metxone — Methadone
MOA: Full agonist at mu-opioid receptors (provides analgesia and reduces withdrawal); also NMDA receptor antagonist (blocks glutamate — useful in neuropathic pain); blocks serotonin and norepinephrine reuptake.
Indications: Opioid use disorder (maintenance/detoxification), severe chronic pain, neuropathic pain.
Side Effects: Respiratory depression, QTc prolongation (Torsades de pointes), sedation, constipation, sweating, physical dependence, risk of overdose with dose accumulation (long half-life).
8. Lanoxin — Digoxin
MOA: Inhibits Na⁺/K⁺-ATPase pump → increases intracellular Na⁺ → increases intracellular Ca²⁺ (via Na⁺/Ca²⁺ exchanger) → positive inotropy. Also increases vagal tone → negative chronotropy (slows heart rate).
Indications: Heart failure with reduced ejection fraction (HFrEF), atrial fibrillation (rate control), atrial flutter.
Side Effects: Narrow therapeutic index — toxicity causes nausea, vomiting, visual disturbances (yellow-green halos), arrhythmias (AV block, VF), bradycardia. Hypokalemia worsens toxicity.
9. Lasix — Furosemide
MOA: Loop diuretic; inhibits Na⁺/K⁺/2Cl⁻ cotransporter (NKCC2) in the thick ascending limb of loop of Henle → prevents reabsorption of Na⁺, Cl⁻, and water → potent diuresis.
Indications: Acute pulmonary edema, heart failure (fluid overload), hypertension, edema (hepatic/renal/cardiac), hypercalcemia, CKD.
Side Effects: Hypokalemia, hyponatremia, hypocalcemia, hypomagnesemia, hypovolemia, ototoxicity (high IV doses), hyperuricemia, metabolic alkalosis.
10. Rovista 10 mg — Rosuvastatin
MOA: HMG-CoA reductase inhibitor (statin); competitively inhibits the rate-limiting step of cholesterol synthesis in the liver → upregulates LDL receptors → reduces LDL-C, total cholesterol, triglycerides; modestly raises HDL-C.
Indications: Hypercholesterolemia, mixed dyslipidemia, primary prevention of cardiovascular events, secondary prevention post-MI/stroke, familial hypercholesterolemia.
Side Effects: Myalgia, myopathy, rhabdomyolysis (rare), elevated transaminases, headache, constipation, proteinuria (high doses), new-onset diabetes mellitus.
11. Saltra 250 mcg — Salmeterol
MOA: Long-acting beta-2 adrenergic agonist (LABA); selectively activates β₂ receptors in bronchial smooth muscle → increases cAMP → bronchodilation (onset slow, duration ~12 hours).
Indications: Maintenance treatment of asthma (always with ICS), COPD, exercise-induced bronchospasm prevention. Never used as monotherapy in asthma (black box warning — increased asthma deaths).
Side Effects: Tachycardia, palpitations, tremor, headache, hypokalemia, worsening of asthma if used alone (without ICS).
12. Alp — Alprazolam
MOA: Benzodiazepine; potentiates GABA-A receptor activity by binding to the benzodiazepine site → enhances Cl⁻ ion influx → CNS depression, anxiolysis, sedation, muscle relaxation, anticonvulsant effect.
Indications: Generalized anxiety disorder (GAD), panic disorder (with/without agoraphobia), short-term anxiety relief.
Side Effects: Sedation, drowsiness, cognitive impairment, anterograde amnesia, dependence/withdrawal, respiratory depression (especially with opioids/alcohol), rebound anxiety on discontinuation.
13. Cap Tephinsta 40 — Pantoprazole 40 mg
MOA: Proton pump inhibitor (PPI); irreversibly binds and inhibits the H⁺/K⁺-ATPase (proton pump) on gastric parietal cells → profoundly reduces gastric acid secretion.
Indications: GERD, peptic ulcer disease (gastric and duodenal), erosive esophagitis, Zollinger-Ellison syndrome, H. pylori eradication (as part of triple therapy), NSAID-induced ulcer prevention.
Side Effects: Headache, nausea, diarrhea, hypomagnesemia (long-term), vitamin B12 deficiency (long-term), C. difficile infection (long-term), osteoporosis/fracture risk (prolonged use), rebound acid hypersecretion on discontinuation.
Note: All medications should be used under medical supervision. Doses, contraindications, and interactions must be evaluated per individual patient.
This is a shared conversation. Sign in to Orris to start your own chat.